Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 11/20 | 0.70 |
| ▸ | CDK4 | P11802 | 8/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | EIF2AK2 | P19525 | 2/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.49 |
| ▸ | BCR | P11274 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.48 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.47 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.47 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2283141 | 0.89 | CDK2 (0.58) | CDK2CDK4MAPTEIF2AK2ABL1 | |
| SCHEMBL2281114 | 0.89 | CDK2 (0.58) | CDK2CDK4MAPTEIF2AK2ABL1 | |
| SCHEMBL2281077 | 0.86 | CDK2 (0.61) | CDK2CDK4CAMK2DPIK3CAPIK3CB | |
| SCHEMBL2286414 | 0.85 | CDK2 (0.52) | CDK2CDK4ABL1BCRPRKCA | |
| SCHEMBL2287260 | 0.84 | CDK2 (0.52) | CDK2CDK4MAPTABL1BCR | |
| SCHEMBL6159474 | 0.83 | CDK2 (1.00) | CDK2CDK4EIF2AK2 | |
| SCHEMBL2283009 | 0.83 | CDK2 (0.83) | CDK2CDK4EIF2AK2ABL1BCR | |
| SCHEMBL2285132 | 0.83 | CDK2 (0.51) | CDK2CDK4MAPTEIF2AK2ABL1 | |
| SCHEMBL2286391 | 0.81 | CDK2 (0.49) | CDK2CDK4MAPTABL1BCR | |
| SCHEMBL2286433 | 0.79 | CDK2 (0.76) | CDK2CDK4MAPTEIF2AK2ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195968-A1 | THIAZOLES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2011-08-11 | — | — | US | disclosed |
| US-20090030024-A1 | THIAZOLES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030024-A1 | THIAZOLES AS FUNGICIDES | CYP4X1, CYP4Z1, RDX | CDK2 2065/4885CDK4 776/4885MAPT 2565/4885 |
| US-20110195968-A1 | THIAZOLES AS FUNGICIDES | CYP4X1, CYP4Z1, CYP3A4 | CDK2 2144/4885CDK4 818/4885MAPT 2586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.